Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation
Gianluigi Savarese, Takuya Kishi, Orly Vardeny, et al.
JACC Heart Failure (2022) Vol. 11, Iss. 1, pp. 1-14
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
Biykem Bozkurt, Tariq Ahmad, Kevin Alexander, et al.
Journal of Cardiac Failure (2023) Vol. 29, Iss. 10, pp. 1412-1451
Open Access | Times Cited: 301
Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization
Ankeet S. Bhatt, Anubodh S. Varshney, Alea Moscone, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 17, pp. 1680-1693
Open Access | Times Cited: 43
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure
Anna Norhammar, Johan Bodegård, Marc Vanderheyden, et al.
Heart (2023), pp. heartjnl-321702
Open Access | Times Cited: 42
Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights
Andrea D’Amato, Silvia Prosperi, Paolo Severino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1574-1574
Open Access | Times Cited: 21
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
Gianluigi Savarese, Felix Lindberg, Antonio Cannatà, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1278-1297
Open Access | Times Cited: 15
Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49
Real‐world use of sodium–glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
Davide Stolfo, Lars H. Lund, Lina Benson, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1648-1658
Open Access | Times Cited: 33
Guideline‐directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP‐HF registry
Daniela Tomasoni, Matteo Pagnesi, Giada Colombo, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 2, pp. 327-337
Open Access | Times Cited: 23
Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy
Jishnu Malgie, Pascal R.D. Clephas, Hans‐Peter Brunner‐La Rocca, et al.
Heart Failure Reviews (2023) Vol. 28, Iss. 5, pp. 1221-1234
Open Access | Times Cited: 22
Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Gianluigi Savarese, Felix Lindberg, Ruxandra Christodorescu, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1408-1418
Open Access | Times Cited: 12
Efficacy of modern therapies for heart failure with reduced ejection fraction in specific population subgroups: a systematic review and network meta-analysis
Carlo Lavalle, Marco Valerio Mariani, Paolo Severino, et al.
Cardiorenal Medicine (2024) Vol. 14, Iss. 1, pp. 570-580
Open Access | Times Cited: 12
Mortality, Health Care Burden, and Treatment of CKD: A Multinational, Observational Study (OPTIMISE-CKD)
Navdeep Tangri, Maria Svensson, Johan Bodegård, et al.
Kidney360 (2024) Vol. 5, Iss. 3, pp. 352-362
Open Access | Times Cited: 9
Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany
Fabian Kerwagen, Christoph Ohlmeier, Thomas Evers, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 6, pp. 931-940
Open Access | Times Cited: 8
Contemporary guideline‐directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE‐HF study
Jishnu Malgie, Mariëlle I. Wilde, Pascal R.D. Clephas, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1549-1560
Open Access | Times Cited: 8
European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC
Amr Abdin, Chris Wilkinson, Suleman Aktaa, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 8
Digital Solutions for the Optimization of Pharmacologic Therapy for Heart Failure
Adam D. DeVore, Mary Norine Walsh, Orly Vardeny, et al.
JACC Heart Failure (2025)
Closed Access | Times Cited: 1
Implementation of guideline‐recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Angiza Shahim, Cecilia Linde, Gianluigi Savarese, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 1
Worsening Heart Failure and Medication Use in HFrEF: A Finnish Retrospective Registry Study and Patient Survey
Aino Vesikansa, Juha Mehtälä, Sarah Smith, et al.
International Journal of Heart Failure (2025) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials
Renzo Laborante, Donato Antonio Paglianiti, Emiliano Bianchini, et al.
European Journal of Internal Medicine (2025)
Open Access | Times Cited: 1
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
Hadi Skouri, Nicolas Girerd, Luca Monzo, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 1
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
Daniela Tomasoni, Beth A. Davison, Marianna Adamo, et al.
Journal of Cardiac Failure (2023) Vol. 30, Iss. 4, pp. 525-537
Open Access | Times Cited: 16
The effect of kidney function on guideline‐directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction
Fanni Bánfi‐Bacsárdi, Dávid Pilecky, Máté Vámos, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 2
Open Access | Times Cited: 6
Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry
Anubodh S. Varshney, Miloni Shah, Sreekanth Vemulapalli, et al.
European Heart Journal (2023) Vol. 44, Iss. 44, pp. 4650-4661
Open Access | Times Cited: 13
Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role
Joycie Chang, Andrew P. Ambrosy, Orly Vardeny, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 12, pp. 1979-1993
Closed Access | Times Cited: 5
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
Lars H. Lund, María G. Crespo‐Leiro, Cécile Laroche, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top